Researchers use AI and genomics to design personalised mRNA cancer vaccine — tumour shrinks >50% in dog with aggressive cancer

Researchers have successfully employed artificial intelligence (AI) and genomics to develop a personalized mRNA cancer vaccine, demonstrating its efficacy in reducing tumor size by over 50% in a dog with aggressive cancer. This breakthrough represents a significant advancement in cancer treatment, leveraging AI-driven analysis of genomic data to tailor the vaccine to an individual's unique tumor profile. The study's findings have sparked enthusiasm in the scientific community, with potential implications for human cancer treatment. The use of AI and genomics in vaccine design could revolutionize the field of oncology, offering a more precise and effective approach to cancer therapy.